All builds

Bioprinting · Extrusion · 2024 · Machines (MDPI)

Extrusion-Based Bioprinting in a Cost-Effective Bioprinter

Three-dimensional (3D) bioprinting has emerged as a revolutionary approach in the life sciences, combining multiple disciplines such as computer engineering, materials science, robotics, and biomedical engineering. This innovative technology enables the production of cellular constructs using bio-inks, and differs from conventional 3D printing by incorporating living cells.

Performance the paper reports

1 of 5
  1. Motion1 µmMotion accuracy: reported
  2. Volume—Volumetric accuracy: not reported
  3. Viability—Cell viability: not reported
  4. Unattended—Unattended operation: not reported
  5. Standard—Standard compliance: not reported
  • Motion / positional accuracy1 µm
    It is also worth noting that, at a measurement precision of 1 µm when using the dial indicator, even the roughness of the contacting surface with the probe can have a profound effect on the measured values of repeatability since the contact

How hard this is to adopt

3.1 of 5, higher is easier

Each score is shown against the range the other 59 builds actually occupy, because no criterion uses the full 1–5 scale. These describe how reproducible the build is, not how good the science is.

  • Resolution

    3/1–5

    Quantitative handling accuracy reported, but minimum volume unclear.

  • Throughput

    3/2–5

    Throughput not explicit; assigned moderate default.

  • Parts sourcing

    2/2–4

    Requires specialized or custom-built components.

  • Skill needed

    4/2–4

    Build/operation described as low-skill or basic assembly.

  • Facilities needed

    3/2–4

    Requires accessible but nontrivial lab/maker equipment.

  • Documentation

    3/2–5

    Some open documentation or files are available.

  • Validation effort

    4/2–4

    Validation includes standards, benchmarking, replicates, or multi-condition tests.

  • Cycle time

    not scored

    No clear speed comparison found

2 further criteria are recorded but not shown
  • Application Level — scored 4 (75% of records share one value), so it cannot separate one build from another.
  • Build Time (scored for only 6 of 60 records), so it cannot separate one build from another.

Both remain in the published dataset.

Have you built this?

Report what it took, including attempts that stalled. A failed build tells the next laboratory what the documentation leaves out.

Report a rebuild

Know what this record is missing?

The index has no licence on the design files, link to the design files or which files exist (CAD, bill of materials, firmware…) for this build. If you are an author or have built it, you know; a GitHub issue pre-filled with this record takes a minute.

Fill the gap
Record metadata
Publication data

Matched by title · retrieved 2026-07-21

Abstract

Three-dimensional (3D) bioprinting has emerged as a revolutionary approach in the life sciences, combining multiple disciplines such as computer engineering, materials science, robotics, and biomedical engineering. This innovative technology enables the production of cellular constructs using bio-inks, and differs from conventional 3D printing by incorporating living cells. The present work addresses the conversion of a commercial thermoplastic 3D printer into a low-cost bioprinter. The modification addresses the challenges of the high cost of commercial bioprinters, limited adaptability, and specialized personnel requirements. This modification uses an extrusion-based bioprinting method that is particularly popular in research due to its viscosity tolerance and versatility. The individual steps, including replacing the extruder with a syringe pump, rebuilding the electronic motherboard, and configuring the firmware, are explained in detail. The work aims at providing access to bioprinting technology so that laboratories with modest resources can take advantage of the immense potential of this technology. This modification resulted in improved resolution, allowing submicron movements, which is comparable to some of the commercially available bioprinters. The accuracy of the modified printer was validated using hydrogel bioprinting tests, suggesting that it is suitable for broader applications in regenerative medicine.

Bibliographic details

Published
2024-07-30
Journal/source
Machines
Publisher
MDPI AG
DOI
10.3390/machines12080518
Type
journal-article
Language
en
Volume / issue
12 / 8
Pages
518
ISSN
2075-1702

Access and metrics

Open access
Yes
OA status
gold
License
cc-by
Version
publishedVersion
Cited by
9
References
70
Retracted
No

Authors and affiliations

  1. Jones Joseph Jebaraj Dharmaraj
  2. Rajesh Jesudoss Hynes NavasinghCorresponding authorOpole University of Technology
  3. Grzegorz KrólczykOpole University of Technology
  4. Shenbaga Velu PitchumaniVellore Institute of Technology University

Topics and keywords

3D Printing in Biomedical ResearchAdditive Manufacturing and 3D Printing TechnologiesInnovative Microfluidic and Catalytic Techniques InnovationMotherboard3D bioprintingComputer scienceNanotechnologyManufacturing engineeringSystems engineeringEngineeringTissue engineeringMaterials scienceBiomedical engineeringComputer hardware
Perspective and practical signals

Why it matters

Potential additional low-cost design reference; needs verification for open files.

Limitations

No limitation note curated yet.